Target light sedation (RASS -1 to 0) with daily awakening, prefer propofol or dexmedetomidine over benzodiazepines, and reserve deep sedation for specific indications.
At the bedside
- 1
Set a target
Document a RASS target every shift (usually -1 to 0); assess RASS every 2-4 h.
- 2
Choose agent
Propofol or dexmedetomidine rather than benzodiazepines; PADIS 2025 suggests dexmedetomidine over propofol for light sedation (less delirium, more time at target, more bradycardia).
- 3
Daily SAT paired with SBT
Stop or reduce sedation daily (if no contraindication) and pair with a spontaneous breathing trial (ABC trial).
- 4
Benzodiazepines only when needed
Alcohol/benzodiazepine withdrawal, seizures, deep sedation when propofol limited, palliative sedation.
- 5
Deep sedation indications
Use with NMB, refractory ICP, status epilepticus; monitor with BIS/EEG where available; reassess daily.
- 6
Weaning
Taper long infusions (> 5-7 days) to avoid iatrogenic withdrawal; consider enteral clonidine or dexmedetomidine to transition.
Sedation
Propofol
- Dose
- 0.3-3 mg/kg/h (max 4 mg/kg/h)
- Preparation
- 1% neat = 10 mg/mL
- Worked example
- 70 kg at 1.5 mg/kg/h = 105 mg/h = 10.5 mL/h (count 1.1 kcal/mL as fat calories)
Light sedation / delirium
Dexmedetomidine
- Dose
- 0.2-1.4 mcg/kg/h, no loading
- Preparation
- 200 mcg in 50 mL NS = 4 mcg/mL
- Worked example
- 70 kg at 0.5 mcg/kg/h = 35 mcg/h = 8.75 mL/h
Deep sedation when needed
Midazolam
- Dose
- 0.02-0.1 mg/kg/h
- Preparation
- 50 mg in 50 mL = 1 mg/mL
- Worked example
- 70 kg at 0.05 mg/kg/h = 3.5 mg/h = 3.5 mL/h
Richmond Agitation-Sedation Scale
| Score | Description |
|---|---|
| +4 | Combative, violent, danger to staff |
| +3 | Very agitated, pulls tubes, aggressive |
| +2 | Agitated, frequent non-purposeful movement, fights ventilator |
| +1 | Restless, anxious, movements not aggressive |
| 0 | Alert and calm |
| -1 | Drowsy, sustained awakening to voice (eye contact > 10 s) |
| -2 | Light sedation, briefly awakens to voice (< 10 s) |
| -3 | Moderate sedation, movement or eye opening to voice, no eye contact |
| -4 | Deep sedation, no response to voice, movement to physical stimulation |
| -5 | Unrousable, no response to voice or physical stimulation |
Calculators for this topic
References
- 1
- 2
- 3
- 4
- 5
- 6
- 7
Sedation titration
Step 1 of ~5
Decision: CPOT > 2 / BPS > 5?
Based on Devlin JW, Skrobik Y, Gelinas C, et al; Lewis K, Balas MC, Stollings JL, et al. Educational use; follow local protocol.
Pathophysiology
Deep sedation in the first 48 h is independently associated with longer ventilation, delirium and death. Benzodiazepines act on GABA-A receptors and are strongly deliriogenic; dexmedetomidine acts on central alpha-2 receptors producing rousable sedation with preserved respiratory drive.
Evidence
- ABC trial: paired SAT + SBT reduced mortality at 1 year [Girard 2008].
- SPICE III (4,000 patients): early dexmedetomidine did not reduce mortality; more bradycardia/hypotension; possible harm in older patients [Shehabi 2019].
- MENDS2: dexmedetomidine vs propofol in sepsis - no difference in delirium-free days [Hughes 2021].
- PADIS 2025: conditional recommendation for dexmedetomidine over propofol for light sedation [Lewis 2025].
Controversies
- Dexmedetomidine vs propofol (MENDS2 neutral vs PADIS 2025 conditional preference); inhaled sedation (volatile agents).
🇮🇳 India notes
- Generic dexmedetomidine and propofol are relatively affordable in India; midazolam infusions remain common due to cost and habit - an important quality-improvement target.
- Infusion pump availability may limit titration in smaller ICUs; intermittent boluses guided by RASS are a fallback.
References
- 1
- 2
- 3
- 4
- 5
- 6
- 7
Test yourself
Module quiz · score 70% to complete the module
Previous
Pain assessment and analgesia-first sedation (PADIS, eCASH)
Next
Delirium: CAM-ICU screening, prevention and management
Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.

